Market Cap

Recce Pharmaceuticals Ltd Market Capitalization:

A$97.9 Million

AUD as of July 1, 2024

US$65.2 Million

business Recce Pharmaceuticals Ltd Company Profile

Recce Pharmaceuticals Ltd Main Stock Listing

ASX: RCE

Market Capitalization History of Recce Pharmaceuticals Ltd

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Top Competitors by Market Capitalization

Industry: Biotechnology
Company Market Cap (USD)
Novo Nordisk $158.96 B
Vertex Pharmaceuticals Incorporated $115.92 B
CSL Limited $95.75 B
Regeneron Pharmaceuticals, Inc. $82.28 B
Marinomed Biotech AG $70.11 B
Sector: Healthcare
Company Market Cap (USD)
Lilly $968.50 B
Johnson & Johnson $499.57 B
AbbVie $405.28 B
Roche $332.12 B
UnitedHealth Group $304.72 B

Yearly evolution of Recce Pharmaceuticals Ltd market cap

Date Market Cap YoY Change
Jan. 1, 2024 A$105.9 M -11.27%
Jan. 1, 2023 A$119.4 M -45.34%
Jan. 1, 2022 A$218.4 M 12.38%
Jan. 31, 2021 A$194.3 M 3.96%
Jan. 1, 2021 A$186.9 M 220.63%
Jan. 31, 2020 A$58.3 M -11.27%
Jan. 1, 2020 A$65.7 M 144.83%
Jan. 31, 2019 A$26.8 M -12.12%
Jan. 1, 2019 A$30.5 M -2.94%
Jan. 31, 2018 A$31.5 M -2.86%
Jan. 1, 2018 A$32.4 M

Market capitalization is calculated from the opening stock price at the beginning of each year.

Recce Pharmaceuticals Ltd Categories

Australia languages Healthcare languages Biotechnology
Australia Healthcare Australia Biotechnology

Stocks & Indices

Recce Pharmaceuticals Ltd has the following listings and related stock indices.


Stock: ASX: RCE

Stock: FSX: R9Q

What is a company's market capitalization?

The market capitalization of a company, more simply referred to as "market cap", is the total market value of a publicly traded company's outstanding shares. It is often considered as a key indicator of what a company is worth.